HABP2 and breast carcinoma: Of the newly identified loci, two (HABP2 and LINC01483) showed associations with MD that are consistent with the MD-breast cancer risk association, suggesting that part of their effect on breast cancer susceptibility is mediated through a directionally consistent change in MD.